Valtteri Kaasinen

Striatal Dopamine Transporter and Rest Tremor in Parkinson Disease: A Clinical Validation hubs.la/Q04bnWg40

Our new Comment in @Nature_NPJ Parkinson’s Disease is out. We discuss the limitations of traditional linear models in PD progression research and argue for more flexible, biologically grounded approaches. With Thilo van Eimeren. rdcu.be/eCCUs

@ValKaasinen @DrJeffRatliff Read the related article in Neurology: neurology.org/doi/10.1212/WN…

In this episode of the Neurology Podcast: Dr. Jeff Ratliff and Dr. Valtteri Kaasinen discuss the clinical challenges of diagnosing #ParkinsonDisease and how that diagnosis can evolve over time. Listen now: hubs.la/Q03FJTcq0 #NeuroTwitter @ValKaasinen @DrJeffRatliff

Overcoming the dopamine-centric model of impulse control disorders in Parkinson’s disease: the role of 5-HT New scientific commentary by Roberto Cilia & Valtteri Kaasinen tinyurl.com/2ffbndxx

Four questions to predict cognitive decline in de novo Parkinson's disease pubmed.ncbi.nlm.nih.gov/40274837/

A new study led by @ValKaasinen from the 🇫🇮 University of Turku and 🇫🇮 @TyksAUCS found that a significant proportion of #Parkinsons disease diagnoses are later corrected. The results demonstrate the need for improved #diagnostic processes. dlvr.it/TKFXcN

Authors: Valtteri Räty, @KuusimakiTomi , Joonas Majuri, Tero Vahlberg, @GardbergMaria , Tommi Noponen, Marko Seppänen, Anna-Maija Tolppanen, @ValKaasinen

We emphasize the need for regular reevalutation of diagnoses, more postmortem examinations and accessible biomarkers. Don’t miss the accompanying editorial, Having Second Thoughts About Parkinson Diagnosis by Ronald Postuma. [neurology.org/doi/10.1212/WN…]

Our latest study in Neurology @GreenJournal reveals significant diagnostic instability in Parkinson's disease, with 13.3-17.7% of diagnoses revised over 10 years. 1/x neurology.org/doi/10.1212/WN…

Sami Heikkinen väitteli tänään parkinsonismista otsalohkorappeumissa, vastaväittäjänä @ValKaasinen ja kustoksena @SoljeEino Hienoa keskustelua tarkan diagnoosin haasteista ja tarpeesta. @UEFneuroscience @kuopio

@UniTurku @TyksAUCS @SohlberginS

Our latest study in Annals of Neurology investigates neuroinflammation in Parkinson's disease and atypical parkinsonisms. Key finding: T-cell-mediated inflammation is significantly higher in progressive supranuclear palsy (PSP). @ANA_journals onlinelibrary.wiley.com/share/author/S…

Accuracy of PD diagnosis: UKBB data onlinelibrary.wiley.com/share/T6VHTXZK…

Propagation of pathologic α-synuclein from kidney to brain may contribute to Parkinson's disease nature.com/articles/s4159…

Prodromal Parkinson's disease and subsequent risk of Parkinson's disease and mortality - PubMed pubmed.ncbi.nlm.nih.gov/39779712/

Bilateral Lesions in Parkinson's Disease: Gaps and Controversies - PubMed pubmed.ncbi.nlm.nih.gov/39726415/

Striatal Dopaminergic Function and Motor Slowing in Essential Tremor Plus - Kuusela - Movement Disorders Clinical Practice - Wiley Online Library …mentdisorders.onlinelibrary.wiley.com/doi/full/10.10… @AinoKuusela

Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in PSP and CBS pubmed.ncbi.nlm.nih.gov/39301998/

Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial - PubMed pubmed.ncbi.nlm.nih.gov/39379705/